These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 30145280)

  • 1. Diagnosis of primary biliary cholangitis in a "teen" male patient.
    Muratori P; Lenzi M; Muratori L
    Clin Res Hepatol Gastroenterol; 2019 Apr; 43(2):e20-e21. PubMed ID: 30145280
    [No Abstract]   [Full Text] [Related]  

  • 2. Autoimmune cholangitis with features of autoimmune hepatitis: successful treatment with immunosuppressive agents and ursodeoxycholic acid.
    Li CP; Tong MJ; Hwang SJ; Luo JC; Co RL; Tsay SH; Chang FY; Lee SD
    J Gastroenterol Hepatol; 2000 Jan; 15(1):95-8. PubMed ID: 10719755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ursodeoxycholic Acid Ameliorates Intrahepatic Cholestasis Independent of Biliary Bicarbonate Secretion in Vil2
    Hatano R; Kawaguchi K; Togashi F; Sugata M; Masuda S; Asano S
    Biol Pharm Bull; 2017; 40(1):34-42. PubMed ID: 28049946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Autoimmune cholestasis syndrome. Ursodeoxycholic acid is the drug standard].
    Stiefelhagen P
    MMW Fortschr Med; 2007 May; 149(21):49. PubMed ID: 17668736
    [No Abstract]   [Full Text] [Related]  

  • 5. Autoimmune cholangitis within the spectrum of autoimmune liver disease.
    Czaja AJ; Carpenter HA; Santrach PJ; Moore SB
    Hepatology; 2000 Jun; 31(6):1231-8. PubMed ID: 10827147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Autoimmune cholangitis or seronegative biliary cirrhosis: report of one case].
    Ndongo S; Mbengue M; Dia D; Seck SM; Ka MM; Moreira Diop T
    Dakar Med; 2008; 53(2):127-30. PubMed ID: 19634547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Autoimmune cholangitis with vasculitic ulcers, rheumatoid arthritis and IgA glomerulonephritis].
    Schedel J; Mayer S; Woenckhaus M; Kiss E; Schölmerich J; Rogler G
    Dtsch Med Wochenschr; 2004 Nov; 129(45):2409-12. PubMed ID: 15529241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Research progress on risk factors for poor response of ursodeoxycholic acid in primary biliary cholangitis].
    Yuan Z; Jia G; Han Y
    Zhonghua Gan Zang Bing Za Zhi; 2019 Jan; 27(1):73-76. PubMed ID: 30685931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of autoimmune hepatic diseases].
    Bueverov AO
    Klin Med (Mosk); 2004; 82(10):62-6. PubMed ID: 15584604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk stratification and treatment of primary biliary cholangitis.
    Martínez J; Aguilera L; Albillos A
    Rev Esp Enferm Dig; 2019 Jan; 111(1):63-70. PubMed ID: 30338693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obstetric cholestasis characterized by extremely elevated serum transaminases.
    Karamouti M; Gerovasilis F; Georgadakis G
    Int J Gynaecol Obstet; 2007 Aug; 98(2):157-8. PubMed ID: 17588573
    [No Abstract]   [Full Text] [Related]  

  • 12. Flare-up of autoimmune hepatitis after delivery in a patient with primary biliary cirrhosis: postpartum overlap syndrome of primary biliary cirrhosis and autoimmune hepatitis.
    Ohba K; Omagari K; Kusakari C; Kadokawa Y; Hayashida K; Takeshima F; Mizuta Y; Murata I; Nakanuma Y; Kohno S
    Dig Dis Sci; 2005 Jan; 50(1):201-6. PubMed ID: 15712661
    [No Abstract]   [Full Text] [Related]  

  • 13. [Cholestatic liver disease].
    Pichler C; Boettler T; Thimme R
    Dtsch Med Wochenschr; 2016 Nov; 141(23):1683-1687. PubMed ID: 27855457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beneficial effect of ursodeoxycholic acid on serum gamma-GTP in patients with biliary atresia following living related liver transplantation.
    Tanaka H; Kita Y; Kawarasaki H; Harihara Y; Ito M; Mizuta K; Terawaki K; Nakahara S; Hashizume K; Makuuchi M
    Transplant Proc; 1998 Nov; 30(7):3326-7. PubMed ID: 9838470
    [No Abstract]   [Full Text] [Related]  

  • 15. The resurgence of serum alkaline phosphatase as a surrogate biomarker for prognosis in primary sclerosing cholangitis.
    Talwalkar JA; Chapman RW
    Clin Gastroenterol Hepatol; 2013 Jul; 11(7):847-9. PubMed ID: 23591287
    [No Abstract]   [Full Text] [Related]  

  • 16. Combined endoscopic and ursodeoxycholic acid treatment of biliary cast syndrome in a non-transplant patient.
    Katsinelos P; Kountouras J; Chatzimavroudis G; Zavos C; Pilpilidis I; Paroutoglou G
    World J Gastroenterol; 2008 Sep; 14(33):5223-5. PubMed ID: 18777601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [No complaints, but constantly elevated cholestatic serum liver tests].
    Kherbèche H
    Praxis (Bern 1994); 2011 Jul; 100(14):865-7. PubMed ID: 21732301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Obeticholic acid for the treatment of primary biliary cholangitis.
    Ali AH; Lindor KD
    Expert Opin Pharmacother; 2016 Sep; 17(13):1809-15. PubMed ID: 27468093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of fatty liver disease with vitamin E and C compared to ursodeoxycholic acid treatment.
    Ersöz G; Günşar F; Karasu Z; Akay S; Batur Y; Akarca US
    Turk J Gastroenterol; 2005 Sep; 16(3):124-8. PubMed ID: 16245220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary Biliary Cholangitis: advances in management and treatment of the disease.
    Invernizzi P; Floreani A; Carbone M; Marzioni M; Craxi A; Muratori L; Vespasiani Gentilucci U; Gardini I; Gasbarrini A; Kruger P; Mennini FS; Ronco V; Lanati E; Canonico PL; Alvaro D
    Dig Liver Dis; 2017 Aug; 49(8):841-846. PubMed ID: 28546061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.